Home > Insider Trading > Filing (0001493152-22-014659)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708331	Virpax Pharmaceuticals Inc.	VRPX	Pharmaceutical Preparations (2834)	821510982

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818483	P. Anthony Mack	1055 Westlakes Drive, Suite 300 Berwyn PA 19312	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	Acquisiton	2022-05-18	75,750	$1.34	252,562	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	2,730,438	Indirect	By Virpax Pharmaceuticals, LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $1.32 to $1.37 per share, inclusive. The Reporting Person undertakes to provide to Virpax Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
The Reporting Person owns 88.8888% of the outstanding member units of Virpax Pharmaceuticals, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.